Search

Your search keyword '"Chen, Kezhong"' showing total 55 results

Search Constraints

Start Over You searched for: Author "Chen, Kezhong" Remove constraint Author: "Chen, Kezhong" Database MEDLINE Remove constraint Database: MEDLINE
55 results on '"Chen, Kezhong"'

Search Results

1. Spatial immunogenomic patterns associated with lymph node metastasis in lung adenocarcinoma.

2. RNA technology and nanocarriers empowering in vivo chimeric antigen receptor therapy.

3. Development and validation of an integrated system for lung cancer screening and post-screening pulmonary nodules management: a proof-of-concept study (ASCEND-LUNG).

4. Expert consensus on the multidisciplinary diagnosis and treatment of multiple ground glass nodule-like lung cancer (2024 Edition).

5. Restoring expression of tumour suppressor PTEN by engineered circular RNA-enhanced Osimertinib sensitivity in non-small cell lung cancer.

6. The current therapeutic cancer vaccines landscape in non-small cell lung cancer.

7. Development of new techniques and clinical applications of liquid biopsy in lung cancer management.

8. Efficacy of neoadjuvant chemo-immunotherapy in non-small cell lung cancer: a real-world, multicenter, retrospective study.

9. Intelligent prognosis evaluation system for stage I-III resected non-small-cell lung cancer patients on CT images: a multi-center study.

10. Individualized tumor-informed circulating tumor DNA analysis for postoperative monitoring of non-small cell lung cancer.

11. Systemic inflammation influences the prognosis of patients with radically resected non-small cell lung cancer and correlates with the immunosuppressive microenvironment.

12. Current and emerging applications of liquid biopsy in pan-cancer.

13. Organ preservation strategies after neoadjuvant chemoimmunotherapy in resectable non-small cell lung cancer: a multicenter retrospective cohort study.

14. Individualized dynamic methylation-based analysis of cell-free DNA in postoperative monitoring of lung cancer.

15. The Prognostic Value of TTF-1/NKX2-1 in Lung Squamous Cell Carcinoma.

16. Multi-omics integrated circulating cell-free DNA genomic signatures enhanced the diagnostic performance of early-stage lung cancer and postoperative minimal residual disease.

17. Lung adenocarcinoma promotion by air pollutants.

18. Towards the molecular era of discriminating multiple lung cancers.

19. Near-infrared fluorescence imaging of thoracic duct in minimally invasive esophagectomy.

20. Potential clinical utility of liquid biopsy in early-stage non-small cell lung cancer.

22. Spatiotemporal genomic analysis reveals distinct molecular features in recurrent stage I non-small cell lung cancers.

24. Research Progress on Postoperative Minimal/Molecular Residual Disease Detection in Lung Cancer.

25. Comprehensive Analysis of Clinical Logistic and Machine Learning-Based Models for the Evaluation of Pulmonary Nodules.

26. Artificial intelligence: opportunities in lung cancer.

28. Multiomics Analysis Reveals Distinct Immunogenomic Features of Lung Cancer with Ground-Glass Opacity.

29. Comparison of Clinical and Pathological Characteristics Between Extremely Multiple GGNs and Single GGNs.

30. Molecular Alterations in Lung Adenocarcinoma With Ground-Glass Nodules: A Systematic Review and Meta-Analysis.

31. Surgical Prognosis of Synchronous Multiple Primary Lung Cancer: Systematic Review and Meta-Analysis.

32. Minimally invasive surgery versus thoracotomy for resectable stage II and III non-small-cell lung cancers: a systematic review and meta-analysis.

33. Development and Validation of Machine Learning-based Model for the Prediction of Malignancy in Multiple Pulmonary Nodules: Analysis from Multicentric Cohorts.

34. Non-invasive lung cancer diagnosis and prognosis based on multi-analyte liquid biopsy.

35. Clinical characteristics and management of primary mediastinal cysts: A single-center experience.

36. Perioperative Dynamic Changes in Circulating Tumor DNA in Patients with Lung Cancer (DYNAMIC).

37. Monitoring of circulating tumor DNA and its aberrant methylation in the surveillance of surgical lung Cancer patients: protocol for a prospective observational study.

38. Application of circulating tumor DNA for dynamic monitoring of advanced non-small cell lung cancer treatment response: An open-label, multicenter, prospective, observational study protocol.

39. Liquid biopsy in newly diagnosed patients with locoregional (I-IIIA) non-small cell lung cancer.

41. The Video-Assisted Thoracic Surgery for Mediastinal Bronchogenic Cysts: A Single-Center Experience.

42. Early metastasis detected in patients with multifocal pulmonary ground-glass opacities (GGOs).

43. Dynamic changes of circulating tumour DNA in surgical lung cancer patients: protocol for a prospective observational study.

44. Favorable prognosis and high discrepancy of genetic features in surgical patients with multiple primary lung cancers.

45. Clinical features, diagnosis and thoracoscopic surgical treatment of thymic cysts.

46. Validation of the Eighth Edition of the TNM Staging System for Lung Cancer in 2043 Surgically Treated Patients With Non-small-cell Lung Cancer.

47. Comparison of plasma to tissue DNA mutations in surgical patients with non-small cell lung cancer.

48. Propensity-matched comparison of video-assisted thoracoscopic with thoracotomy lobectomy for locally advanced non-small cell lung cancer.

49. [Clinical features and treatment outcome of multiple primary lung cancer patients with different imaging performance].

50. Risk factors of recurrence for resected T1aN0M0 invasive lung adenocarcinoma: a clinicopathologic study of 177 patients.

Catalog

Books, media, physical & digital resources